Top Abstract Purchase Related
Home
>
Node
>
Subnode

Autopsy findings in an elderly man suffering from severe von Willebrand's disease

Kernoff, L.M.; Rose, A.G.; Hughes, J.; Jacobs, P.

Thrombosis and Haemostasis 46(4): 714-716

1981

ISSN/ISBN: 0340-6245
PMID: 6977199
Document Number: 173365
A platelet derived growth factor released following platelet adhesion to the subendothelium of damaged arteries may promote the development of atherosclerotic lesions. Consequently patients with von Willebrand's disease in whom platelet adhesion is abnormal may be protected from atherosclerosis. This possibility was investigated by performing an autopsy study on an elderly patient who had suffered from severe von Willebrand's disease. Extensive atherosclerotic lesions were found at post mortem suggesting that platelets may not play a clinically significant role in the causation of atherosclerosis.

Document emailed within 1 workday
Secure & encrypted payments

Shibata, A.; Takahashi, H. 1981: Recent findings on von Willebrand's disease Nihon Rinsho. Japanese Journal of Clinical Medicine 39(12): 3657-3665
Orlov, V.N.; Trotsenko, S.N. 2009: Universal suture technique in operative treatment of recurrent sygmoid colon volvulus in elderly and senile patients suffering severe concurrent diseases Klinichna Khirurhiia 5: 59-60
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Silva, C.D.; Geraldes, F.; Silva, I.S. 2013: Levonorgestrel intrauterine system as a treatment option for severe menorrhagia in adolescent with type IIi von Willebrand disease BMJ Case Reports
Kahn, L.B.; Novis, B.H. 1977: Alpha-chain disease. A case report with autopsy findings South African Medical Journal 51(26): 984-989
Wolkenstein, P.; Consoli, S.; Roujeau, J.C.; Grob, J.J. 2002: The physician-patient relation. Reporting a severe disease. Education of a patient suffering from a chronic disease. Personalizing medical management Annales de Dermatologie et de Venereologie 129(10 Suppl): S7-10
Arghir, O.C.; Ionescu, F.C.; Apostol, A. 2012: Severe transfuse related acute lung injury (TRALI) syndrome in a 14 years old girl with a history of type I von Willebrand disease Pneumologia 61(3): 175-177
Fukui, H.; Yoshioka, A.; Mikami, S.; Takase, T.; Fujimura, Y.; Takahashi, Y.; Nishino, M.; Iwagaki, K. 1979: Pathophysiology of von Willebrand's disease: Qualitative and quantitative analysis of von Willebrand protein Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 42(6): 839-850
Fukui, H.; Okuda, T.; Takase, T.; Mikami, S.; Yoshioka, A.; Fujimura, Y.; Yoshioka, K. 1978: Two cases of atypical von Willebrand's disease with inhibitory effect on von Willebrand factor Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(5): 897-907
Piao, Y.C.; Lavergne, J.M.; Boyer-Neumann, C.; Schandelong, A.; Alessi, M.C.; Meyer, D. 1993: Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand disease Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 4(5): 787-789
Nichols, T.C.; Bellinger, D.A.; Reddick, R.L.; Read, M.S.; Koch, G.G.; Brinkhous, K.M.; Griggs, T.R. 1991: Role of von Willebrand factor in arterial thrombosis. Studies in normal and von Willebrand disease pigs Circulation 83(6): Iv56-Iv64
Takahashi, H. 1981: Studies on the pathophysiology and treatment of von Willebrand's disease. II. Gel filtration studies on plasma factor VIIi in von Willebrand's disease Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 44(1): 165-172
Rastegar-Lari, G.; Ajzenberg, N.; Ribba, A.S.; Vereycken-Holler, V.; Legendre, P.; Villoutreix, B.; Meyer, D.; Baruch, D. 2001: Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations Thrombosis and Haemostasis 86(6): 1459-1465
Simpson, R.W.; Edwards, W.D. 1986: Pathogenesis of cocaine-induced ischemic heart disease. Autopsy findings in a 21-year-old man Archives of Pathology and Laboratory Medicine 110(6): 479-484
Inbal, A.; Kornbrot, N.; Harrison, P.; Randi, A.M.; Sadler, J.E. 1993: Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor Thrombosis and Haemostasis 70(6): 1058-1062
Khoroshinina, L.P.; Tur'eva, L.V.; Radchenko, V.G.; Kochergina, T.A. 2014: Fatty liver in elderly patients with atherosclerotic coronary artery disease (according to autopsy data) Eksperimental'naia i Klinicheskaia Gastroenterologiia 8: 54-59
Foster, P.A. 1995: The reproductive health of women with von Willebrand Disease unresponsive to DDAVP: results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 74(2): 784-790
Sultan, Y.; Simeon, J.; Caen, J.P. 1976: Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease Journal of Laboratory and Clinical Medicine 87(2): 185-194
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468
Lethagen, S.; Isaksson, C.; Schaedel, C.; Holmberg, L. 2002: Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X) Thrombosis and Haemostasis 88(3): 421-426